Monitoring emerging HIV drug resistance in sub-Saharan Africa in the era of dolutegravir.

Dolutegravir-based regimens are now standard of care for HIV treatment for millions of people around Sub-Saharan Africa. To ensure its continued efficacy, monitoring of emerging drug resistance that inform a treatment strategy amongst those failing is crucial. Here we outline the plan by the President Emergence Plan for AIDS Relief to leverage viral load infra structure to implement effective drug resistance surveillance in the countries it supports.